Atossa Therapeutics, Inc.
(NASDAQ : ATOS)

( )
ATOS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.00%477.181.0%$1021.77m
DHRDanaher Corp. 0.02%223.380.7%$675.93m
BSXBoston Scientific Corp. -0.06%33.791.0%$538.78m
MDTMedtronic Plc 0.13%112.610.6%$538.77m
ABTAbbott Laboratories -0.03%107.500.8%$512.50m
BDXBecton, Dickinson & Co. -0.02%238.471.0%$431.05m
ISRGIntuitive Surgical, Inc. 0.00%758.722.3%$403.34m
DXCMDexCom, Inc. 0.00%344.637.8%$389.91m
ALGNAlign Technology, Inc. 0.00%511.006.4%$338.48m
BAXBaxter International, Inc. -0.04%76.291.8%$305.46m
SYKStryker Corp. -0.11%234.521.3%$285.85m
QDELQuidel Corp. 0.00%200.997.7%$241.62m
AAgilent Technologies, Inc. -0.07%113.501.6%$228.36m
EWEdwards Lifesciences Corp. -0.10%83.570.4%$221.64m
IDXXIDEXX Laboratories, Inc. 0.00%460.073.8%$209.92m

Company Profile

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. The ArgusCYTE Breast Health Test offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.